These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 25338682)

  • 1. Unveiling transcription factor regulation and differential co-expression genes in Duchenne muscular dystrophy.
    Tian L; Cao J; Deng X; Zhang C; Qian T; Song X; Huang B
    Diagn Pathol; 2014 Oct; 9():210. PubMed ID: 25338682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of hub genes, miRNAs and regulatory factors relevant for Duchenne muscular dystrophy by bioinformatics analysis.
    Xiu MX; Zeng B; Kuang BH
    Int J Neurosci; 2022 Mar; 132(3):296-305. PubMed ID: 32791870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Hub Genes in Duchenne Muscular Dystrophy: Evidence from Bioinformatic Analysis.
    Zhang R; Lv L; Ban W; Dang X; Zhang C
    J Comput Biol; 2020 Jan; 27(1):1-8. PubMed ID: 31390219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying the hub genes for Duchenne muscular dystrophy and Becker muscular dystrophy by weighted correlation network analysis.
    Wang J; Fan Q; Yu T; Zhang Y
    BMC Genom Data; 2021 Dec; 22(1):57. PubMed ID: 34922439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of transcriptional factors and key genes in primary osteoporosis by DNA microarray.
    Xie W; Ji L; Zhao T; Gao P
    Med Sci Monit; 2015 May; 21():1333-44. PubMed ID: 25957414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene regulation networks in early phase of Duchenne muscular dystrophy.
    Bernardini C; Censi F; Lattanzi W; Calcagnini G; Giuliani A
    IEEE/ACM Trans Comput Biol Bioinform; 2013; 10(2):393-400. PubMed ID: 23929863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of hub genes related to Duchenne muscular dystrophy by weighted gene co-expression network analysis.
    Wei Y; Su Q; Li X
    Medicine (Baltimore); 2022 Dec; 101(52):e32603. PubMed ID: 36596079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulated mechanisms underlying Duchenne muscular dystrophy from co-expression network preservation analysis.
    Mukund K; Subramaniam S
    BMC Res Notes; 2015 May; 8():182. PubMed ID: 25935398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovering Promising Biomarkers and Therapeutic Targets for Duchenne Muscular Dystrophy: a Multiomics Meta-Analysis Approach.
    Elasbali AM; Al-Soud WA; Adnan M; Alhassan HH; Mohammad T; Hassan MI
    Mol Neurobiol; 2024 Aug; 61(8):5117-5128. PubMed ID: 38165583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression profiling of Duchenne muscular dystrophy reveals characteristics along disease progression.
    Tian LJ; Cao JH; Deng XQ; Zhang CL; Qian T; Song XX; Huang BS
    Genet Mol Res; 2014 Feb; 13(1):1402-11. PubMed ID: 24634239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential co-expression analysis of rheumatoid arthritis with microarray data.
    Wang K; Zhao L; Liu X; Hao Z; Zhou Y; Yang C; Li H
    Mol Med Rep; 2014 Nov; 10(5):2421-6. PubMed ID: 25118911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression of OCT4, SOX2, KLF4 and MYC (OSKM) induced pluripotent stem cells: identification for potential mechanisms.
    Cai Y; Dai X; Zhang Q; Dai Z
    Diagn Pathol; 2015 Apr; 10():35. PubMed ID: 25907774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of upstream regulators for synovial expression signature genes in osteoarthritis.
    Fei Q; Lin J; Meng H; Wang B; Yang Y; Wang Q; Su N; Li J; Li D
    Joint Bone Spine; 2016 Oct; 83(5):545-51. PubMed ID: 26832188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-X-C motif chemokine ligand 12: a potential therapeutic target in Duchenne muscular dystrophy.
    Lai X; Chen J
    Bioengineered; 2021 Dec; 12(1):5428-5439. PubMed ID: 34424816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive Analysis of Long Non-coding RNA-Associated Competing Endogenous RNA Network in Duchenne Muscular Dystrophy.
    Xu X; Hao Y; Xiong S; He Z
    Interdiscip Sci; 2020 Dec; 12(4):447-460. PubMed ID: 32876881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Network Medicine Approach for Drug Repurposing in Duchenne Muscular Dystrophy.
    Lombardo SD; Basile MS; Ciurleo R; Bramanti A; Arcidiacono A; Mangano K; Bramanti P; Nicoletti F; Fagone P
    Genes (Basel); 2021 Apr; 12(4):. PubMed ID: 33918694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel approach to meta-analysis of microarray datasets reveals muscle remodeling-related drug targets and biomarkers in Duchenne muscular dystrophy.
    Kotelnikova E; Shkrob MA; Pyatnitskiy MA; Ferlini A; Daraselia N
    PLoS Comput Biol; 2012 Feb; 8(2):e1002365. PubMed ID: 22319435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of key genes and transcription factors in aging mesenchymal stem cells by DNA microarray data.
    Wu Y; Yang J; Ai Z; Yu M; Li J; Li S
    Gene; 2019 Apr; 692():79-87. PubMed ID: 30641220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of immune-related features involved in Duchenne muscular dystrophy: A bidirectional transcriptome and proteome-driven analysis.
    Wu X; Dong N; Yu L; Liu M; Jiang J; Tang T; Zhao H; Fang Q
    Front Immunol; 2022; 13():1017423. PubMed ID: 36483550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of pathogenic genes and upstream regulators in allergic rhinitis.
    Lei Y; Guo P; An J; Guo C; Lu F; Liu M
    Int J Pediatr Otorhinolaryngol; 2018 Dec; 115():97-103. PubMed ID: 30368403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.